Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Safety and Efficacy of Celecoxib in Patients With PD
NCT07246278Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in Parkinson's disease (PD), sponsored by Tanta University. Started Nov 2025; status: recruiting.
02
Drugs
celecoxib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07246278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246278.